(Q78309903)
Statements
Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease (English)
Geert D'Haens
Severine Vermeire
Edouard Louis
Paul Rutgeerts
Maja Noman
Jacques Belaiche
Andre Van Gossum
An Carbonez
Gert Van Assche
Martine De Vos
Paul Pescatore
Paul Pelckmans
Hendrik Reynaert
Belgian Group of Infliximab Expanded Access Program in Crohn's Disease
1 September 2002
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference